Lipid Management in an Era of Evolving Evidence

This activity is supported by educational funding provided by Amgen; Esperion Therapeutics, Inc.; Merck & Co., Inc.; and Novartis Pharmaceuticals Corporation.


1.75CME
1.75AAPA
1.75CNE
1.75ABIM MOC
1.75CPE
105MINS
H704_HEA001_OG_1200x630

Overview

Provider Statement

This continuing education activity is provided by Vindico Medical Education

Educational Partner

National Lipid Association


Support Statement

This activity is supported by educational funding provided by Amgen; Esperion Therapeutics, Inc.; Merck & Co., Inc.; and Novartis Pharmaceuticals Corporation.


Activity Description

Clinicians face increasing complexity in atherosclerotic cardiovascular disease (ASCVD) prevention as new data highlight the importance of cumulative low-density lipoprotein cholesterol (LDL-C) exposure, the impact of elevated lipoprotein(a) (Lp[a]), and the expanding role of combination therapy and nonstatin agents. In response, recently updated guidelines refine recommendations for risk assessment, establish target thresholds for treatment, and emphasize earlier management to reduce lifelong exposure to atherogenic lipoproteins. This case-based CME activity will review key recommendations for primary and secondary prevention of ASCVD and engage learners through clinical scenarios in which expert faculty will discuss practical implementation of the updated guidelines. 


Target Audience

The intended audience for this activity is physicians and advanced practice providers specializing in cardiology as well as internists, endocrinologists, pharmacists, nurses, and all others involved in the management of patients with or at risk of ASCVD.


Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Recognize the impact of cumulative LDL-C exposure on cardiovascular risk.
  • Examine the rationale for Lp(a) screening as an important part of cardiovascular risk assessment.
  • Review updated guideline recommendations for the primary prevention of cardiovascular disease.
  • Evaluate the latest clinical evidence for current and emerging lipid-lowering therapies.
  • Discuss strategies to improve the knowledge, skills, or performance of the healthcare team.

Activity Chair

James A. Underberg, MD, MS, FACP, FACPM, FASH, MNLA
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
Past-President, National Lipid Association
Past-President, American Board of Clinical Lipidology
Diplomate, American Board of Clinical Lipidology
New York, NY


Faculty

Zahid Ahmad, MD, FNLA
Associate Professor of Internal Medicine
Lipid Section, Division of Endocrinology
Department of Internal Medicine
UT Southwestern Medical Center
Director
Lipid Clinic, Parkland Health and Hospital Systems
Co-Director
Familial Hypercholesterolemia Clinic
UT Southwestern
Dallas, TX

Heather M. Johnson, MD, MS, MMM, FAHA, FACC, FASPC
Director of Preventive Cardiology for Women's Services
Christine E. Lynn Women's Health & Wellness Institute
Baptist Health South Florida - North Medical Group
Clinical Affiliate Associate Professor, Florida Atlantic University
Boca Raton, FL

Jessica M. Peña, MD, MPH, FNLA, FACC
Associate Professor
Director, HeartHealth Program
Weill Cornell Medicine/New York Presbyterian Hospital
New York, NY


Planners/Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Susan Halli-Demeter, DNP
Jennifer Frederick, PharmD, BCPS
Linda A. Giarraputo, BS, PA-C
Barbara A. Niedz, PhD, RN, CPHQ


Accreditation

ACCME Jointly accredited  In support of improving patient care, this activity has been planned and implemented by Vindico Medical Education and National Lipid Association. Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

abimSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt in by providing their ABIM ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CME credits claimed for the activity.

aapaVindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Vindico Medical Education designates this activity for 1.75 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.

acpe_logo_100pxThis program is acceptable for 1.75 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is JA0006104-9999-26-009-H01-P, effective 08/06/2026. This is a knowledge-based activity, and there is no fee to attend.

*IMPORTANT* Pharmacists MUST request credit within 60 days of activity completion. Upon receipt of the completed activity evaluation form, transcript information will be available at CPE Monitor within 4 weeks.

This enduring material is approved for 1 year from the date of original release, August 6, 2026, to August 5, 2027.


How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 out of 6 of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate, AAPA Category 1 CME Certificate, Contact Hour Certificate, or Statement of Continuing Pharmacy Education Credit.

In addition to providing a downloadable certificate, CME Providers accredited by the Accreditation Council for Continuing Medical Education (ACCME) have the ability to transmit CME credit data for all US physicians to an online repository, the ACCME Program and Activity Reporting System (PARS). CME credit data submitted to PARS can be viewed, managed, and tracked by US physicians in "CME Passport," a free, centralized web application. US physicians who opt-in by providing their medical license number, state of licensure, and date of birth will have their credits automatically reported to the ACCME.


Disclosures

Vindico Medical Education and National Lipid Association adhere to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible companies. All relevant financial relationships with ineligible companies have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Zahid Ahmad, MD, FNLA
Consultant: Ionis
Independent Research Contractor: Ionis

Heather M. Johnson, MD, MS, MMM, FAHA, FACC, FASPC
Consultant: Amgen, Esperion, Medtronic, Novartis
Speaker Contracted by Ineligible Company: Esperion

Jessica M. Peña, MD, MPH, FNLA, FACC
Advisor: Merck, Novartis, Novo Nordisk

James A. Underberg, MD, MS, FACP, FACPM, FASH, MNLA
Advisor: Arrowhead, Esperion, Ionis, NewAmsterdam, Regeneron
Consultant: Amgen, Arrowhead
Speaker Contracted by Ineligible Company: Amgen, Arrowhead, Chiesi, Ionis, Regeneron
Independent Research Contractor: Chiesi
Data Safety Monitoring Board: Marea

Planners/Reviewers report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.

Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose.

Susan Halli-Demeter, DNP
No relevant financial relationships to disclose.

Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.

Vindico Medical Education and National Lipid Association staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance and National Lipid Association.


Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Accessibility

Vindico Medical Education is committed to providing an inclusive learning environment and ensuring equitable access to our educational content. Our educational activities may include accessibility features, such as captioning, transcripts, reading aloud, and other platform-supported tools, to assist learners.

Participants who require additional accommodation, alternative formats, or assistance accessing content are encouraged to contact us at CME@VindicoCME.com. Vindico will make all reasonable efforts to provide alternative formats in a timely manner.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2026 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education and National Lipid Association continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education or National Lipid Association. Neither Vindico Medical Education, National Lipid Association, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


Procedures for Reporting Copyright Infringement

If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:

  • Specify the copyrighted work you believe has been infringed upon.
  • Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
  • Share your name, address, telephone number, and, if available, your email address.
  • Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
  • Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
  • Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.

Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614


CE Questions?

Contact us at cme@vindicoCME.com